Susquehanna International Group’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.4M | Sell |
52,834
-29,921
| -36% | -$876K | ﹤0.01% | 7073 |
|
|
2025
Q4 | $2.4M | Sell |
82,755
-6,799
| -8% | -$204K | ﹤0.01% | 5267 |
|
|
2025
Q3 | $2.49M | Buy |
89,554
+28,470
| +47% | +$719K | ﹤0.01% | 5327 |
|
|
2025
Q2 | $1.49M | Buy |
61,084
+4,855
| +9% | +$106K | ﹤0.01% | 6463 |
|
|
2025
Q1 | $1.17M | Sell |
56,229
-40,170
| -42% | -$1.01M | ﹤0.01% | 6867 |
|
|
2024
Q4 | $2.27M | Buy |
96,399
+14,519
| +18% | +$357K | ﹤0.01% | 5018 |
|
|
2024
Q3 | $2.1M | Sell |
81,880
-23,190
| -22% | -$590K | ﹤0.01% | 5179 |
|
|
2024
Q2 | $2.47M | Buy |
105,070
+75,878
| +260% | +$1.91M | ﹤0.01% | 4679 |
|
|
2024
Q1 | $840K | Sell |
29,192
-29,616
| -50% | -$891K | ﹤0.01% | 7300 |
|
|
2023
Q4 | $1.93M | Sell |
58,808
-4,140
| -7% | -$113K | ﹤0.01% | 5434 |
|
|
2023
Q3 | $1.75M | Buy |
62,948
+17,164
| +37% | +$561K | ﹤0.01% | 5399 |
|
|
2023
Q2 | $1.56M | Sell |
45,784
-40,157
| -47% | -$1.26M | ﹤0.01% | 5678 |
|
|
2023
Q1 | $2.58M | Buy |
85,941
+27,813
| +48% | +$862K | ﹤0.01% | 4621 |
|
|
2022
Q4 | $1.64M | Buy |
58,128
+44,569
| +329% | +$1.41M | ﹤0.01% | 5089 |
|
|
2022
Q3 | $446K | Sell |
13,559
-213,317
| -94% | -$7.83M | ﹤0.01% | 8790 |
|
|
2022
Q2 | $7.14M | Buy |
226,876
+110,311
| +95% | +$3.86M | ﹤0.01% | 2661 |
|
|
2022
Q1 | $5.35M | Buy |
116,565
+35,828
| +44% | +$1.71M | ﹤0.01% | 3526 |
|
|
2021
Q4 | $4.94M | Sell |
80,737
-28,291
| -26% | -$1.96M | ﹤0.01% | 3756 |
|
|
2021
Q3 | $8.15M | Buy |
109,028
+54,832
| +101% | +$4.6M | ﹤0.01% | 3173 |
|
|
2021
Q2 | $5.01M | Sell |
54,196
-41,223
| -43% | -$3.5M | ﹤0.01% | 4035 |
|
|
2021
Q1 | $8.47M | Buy |
95,419
+54,257
| +132% | +$5.38M | ﹤0.01% | 3047 |
|
|
2020
Q4 | $3.84M | Buy |
41,162
+4,669
| +13% | +$372K | ﹤0.01% | 3886 |
|
|
2020
Q3 | $2.33M | Buy |
+36,493
| New | +$2.14M | ﹤0.01% | 4335 |
|
|
2020
Q2 | – | Sell |
-21,329
| Closed | -$667K | – | 10077 |
|
|
2020
Q1 | $667K | Sell |
21,329
-7,465
| -26% | -$249K | ﹤0.01% | 6308 |
|
|
2019
Q4 | $965K | Buy |
28,794
+1,534
| +6% | +$48.7K | ﹤0.01% | 5612 |
|
|
2019
Q3 | $805K | Sell |
27,260
-2,885
| -10% | -$93.8K | ﹤0.01% | 6175 |
|
|
2019
Q2 | $1.04M | Sell |
30,145
-445
| -1% | -$14.3K | ﹤0.01% | 5564 |
|
|
2019
Q1 | $1.01M | Buy |
30,590
+13,578
| +80% | +$401K | ﹤0.01% | 5034 |
|
|
2018
Q4 | $408K | Buy |
17,012
+3,392
| +25% | +$95.6K | ﹤0.01% | 6403 |
|
|
2018
Q3 | $455K | Sell |
13,620
-658
| -5% | -$20.8K | ﹤0.01% | 6707 |
|
|
2018
Q2 | $415K | Buy |
+14,278
| New | +$397K | ﹤0.01% | 7181 |
|
|
2017
Q4 | – | Sell |
-9,267
| Closed | -$243K | – | 9198 |
|
|
2017
Q3 | $243K | Buy |
+9,267
| New | +$218K | ﹤0.01% | 7724 |
|
Other funds holding ARKG
Susquehanna International Group's ARKG Position: Q1 2026 in Review
Susquehanna International Group reduced its ARK Genomic Revolution ETF (ARKG) stake by 36% in Q1 2026, selling an estimated $876K and leaving 52,834 shares worth $1.4M. The position accounts for ﹤0.01% of the portfolio, ranked #7073.
Susquehanna International Group first reported a position in ARKG in Q3 2017 and has held it in 32 quarters since. The position peaked at $8.47M in Q1 2021. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.
- Susquehanna International Group held 52,834 shares of ARK Genomic Revolution ETF worth $1.4M as of Q1 2026.
- Susquehanna International Group sold 29,921 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $876K.
- ARK Genomic Revolution ETF made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7073 holding.
- Susquehanna International Group first reported a position in ARK Genomic Revolution ETF in Q3 2017 and has held it in 32 quarters since.
- Susquehanna International Group's ARK Genomic Revolution ETF position peaked at $8.47M in Q1 2021.
- 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.